Share Email Print

Proceedings Paper

Development of image-guided targeted two-photon PDT for the treatment of head and neck cancers
Author(s): Charles W. Spangler; Jean R. Starkey; Bo Liang; Sara Fedorka; Hao Yang; Huabei Jiang
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

There has been significant effort over the past two decades in the treatment of malignancies of epithelial origin, including some of the most devastating of cancers, such as colorectal cancer (CRC), squamous call carcinoma of the head and neck (HNSCC), and carcinomas of the pancreas, lungs, (both Small Cell and Non-Small Cell), renal cell, prostate, bladder and breast. Recurring, refractory HNSCC is a particularly difficult cancer to treat once the tumors recur due to mutations that are resistant to repeat chemotherapy and radiation. In addition, repeat surgery is often difficult due to the requirement of significant surgical margins that may not be possible due to the attending potential functional deficits (e.g., salivary glands, nerves and major blood vessels in confined areas). In this study FaDu HNSCC xenograft tumors in SCID mice were imaged, and “optical”, as opposed to “surgical” margins defined for the tumor being treated. The subsequent two-photon treatment irradiation was computer-controlled to carry out the tumor treatment by rastering the laser beam throughout the tumor volume plus the defined optical margins simultaneously. In our initial studies, up to 85% regression in tumor volume was observed in 5 days post PDT, with complete tumor regression in 18 days. No re-growth was observed up to 41 days post-PDT, with little or no scarring and complete hair re-growth. However, competition between imaging and PDT moieties was also observed in some mouse models, possibly favoring tumor re-growth. Strategies to selectively optimize the PDT effect will be discussed.

Paper Details

Date Published: 14 March 2014
PDF: 8 pages
Proc. SPIE 8931, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXIII, 89310C (14 March 2014); doi: 10.1117/12.2043070
Show Author Affiliations
Charles W. Spangler, SensoPath Technologies, Inc. (United States)
Jean R. Starkey, Montana State Univ. (United States)
Bo Liang, SensoPath Technologies, Inc. (United States)
Sara Fedorka, SensoPath Technologies, Inc. (United States)
Hao Yang, Univ. of Florida (United States)
Huabei Jiang, Univ. of Florida (United States)

Published in SPIE Proceedings Vol. 8931:
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXIII
David H. Kessel; Tayyaba Hasan, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?